Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8429018 | Best Practice & Research Clinical Haematology | 2018 | 8 Pages |
Abstract
Follicular lymphoma is the most common indolent non-Hodgkin lymphoma. Advanced stage disease is common at diagnosis. The timing of treatment for follicular lymphoma is best approached by considering the combination of presence or absence of symptoms along with estimation of tumor burden. Upfront treatment strategies should take into initial presentation variables, pace of disease progression and goals of care after discussion with the patient. Treatment approaches remain diverse and patient discernment is paramount.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jayadev Manikkam Umakanthan, Mathew A. Lunning,